In this study, high-performance liquid chromatography with fluorescence detection (HPLC-FLD) has been used for the first time, for direct determination of warfarin and its major metabolite, 7-hydroxywarfarin, in rat plasma. The simple and sensitive method was developed using Fortis® reversed-phase diphenyl column (150 × 4.6 mm, 3 μm) and a mobile phase composed of phosphate buffer (25 mmol L−1)/methanol/acetonitrile (70:20:10, V/V/V), adjusted to pH 7.4, at a flow rate of 0.8 mL min−1. The diphenyl chemistry of the stationary phase provided a unique selectivity for separating the structurally related aromatic analytes, warfarin and 7-hydroxywarfarin, allowing their successful quantification in the complex plasma matrix. The method was linear over the range 0.01–25 μg mL−1, for warfarin and 7-hydroxywarfarin, and was found to be accurate, precise and selective in accordance with US FDA guidance for bioanalytical method validation. The method was sensitive enough to quantify 0.01 μg mL−1 of warfarin and 7-hydroxywarfarin (LLOQ) using only 100 μL of plasma. The applicability of this method was demonstrated by analyzing samples obtained from rats after oral administration of a single warfarin dose, and studying warfarin and 7-hydroxywarfarin pharmacokinetics.
2. M. Wadelius, L. Chen, K. Downes, J. Ghori, S. Hunt, N. Eriksson, O. Wallerman, H. Melhus, C. Wadelius and D. Bentley, Common VKORC1 and GGCX polymorphisms associated with warfarin dose, Pharmacogen. J.5 (2005) 262–270; https://doi.org/10.1038/sj.tpj.6500313
7. R. A. O’Reilly, Warfarin Metabolism and Drug-drug Interactions, in The New Dimensions of Warfarin Prophylaxis (Eds. S. Wessler, C. G. Becker and Y. Nemerson), Springer, Boston (MA) 1987, pp. 205–212.
8. C. Guo, S. Xue, X. Zheng, Y. Lu, D. Zhao, X. Chen and N. Li, The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats, Xenobiotica48 (2017) 400–406; https://doi.org/10.1080/00498254.2017.1306760
11. M. Ufer, B. Kammerer, J. Kirchheiner, A. Rane and J.-O. Svensson, Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography–mass spectrometry after solid-phase extraction, J. Chromatogr. B809 (2004) 217–226; https://doi.org/10.1016/j.jchromb.2004.06.023
12. Q. Zhou, W. P. Yau and E. Chan, Enantioseparation of warfarin and its metabolites by capillary zone electrophoresis, Electrophoresis24 (2003) 2617–2626; https://doi.org/10.1002/elps.200305441
13. Z. Zuo, S. K. Wo, C. M. Y. Lo, L. Zhou, G. Cheng and J. H. S. You, Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography–tandem mass spectrometry, J. Pharm. Biomed. Anal.52 (2010) 305–310; https://doi.org/10.1016/j.jpba.2010.01.005
14. L. D. Heimark, L. Wienkers, K. Kunze, M. Gibaldi, A. C. Eddy, W. F. Trager, R. A. O’Reilly and D. A. Goulart, The mechanism of the interaction between amiodarone and warfarin in humans, Clin. Pharmacol. Ther.51 (1992) 398–407; https://doi.org/10.1038/clpt.1992.39
15. A. H. Salem, B. Hu, K. J. Freise, S. K. Agarwal, D. S. Sidhu and S. L. Wong, Evaluation of the pharmacokinetic interaction between venetoclax, a selective BCL-2 Inhibitor, and warfarin in healthy volunteers, Clin. Drug Invest.37 (2017) 303–309; https://doi.org/10.1007/s40261-016-0485-9
16. D. K. Kumar, D. G. Shewade, S. Parasuraman, S. Rajan, J. Balachander, B. V. S. Chandran and C. Adithan, Estimation of plasma levels of warfarin and 7-hydroxy warfarin by high performance liquid chromatography in patients receiving warfarin therapy, J. Young Pharm.5 (2013) 13–17; https://doi.org/10.1016/j.jyp.2013.02.001
17. I. Locatelli, V. Kmetec, A. Mrhar and I. Grabnar, Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation, J. Chromatogr. B818 (2005) 191–198; https://doi.org/10.1016/j.jchromb.2004.12.024
18. W. Naidong and J. W. Lee, Development and validation of a high-performance liquid chromatographic method for the quantitation of warfarin enantiomers in human plasma, J. Pharm. Biomed. Anal.11 (1993) 785–792; https://doi.org/10.1016/0731-7085(93)80070-H
19. H. Takahashi, T. Kashima, S. Kimura, N. Muramoto, H. Nakahata, S. Kubo, Y. Shimoyama, M. Kajiwara and H. Echizen, Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection, J. Chromatogr. B701 (1997) 71–80; https://doi.org/10.1016/S0378-4347(97)00346-0
20. T. Lomonaco, S. Ghimenti, I. Piga, M. Onor, B. Melai, R. Fuoco and F. Di Francesco, Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection, J. Chromatogr. A1314 (2013) 54–62; https://doi.org/10.1016/j.chroma.2013.08.091
21. A. Qayyum, M. H. Najmi, A. M. Khan, M. Abbas, A. K. Naveed and A. Jameel, Determination of S-and R-warfarin enantiomers by using modified HPLC method, Pak. J. Pharm. Sci.28 (2015) 1315–1321.
22. C. Huang, J. Yang, Y. Du and L. Miao, Measurement of free concentrations of highly protein-bound warfarin in plasma by ultra performance liquid chromatography–tandem mass spectrometry and its correlation with the international normalized ratio, Clin. Chim. Acta393 (2008) 85–89; https://doi.org/10.1016/j.cca.2008.03.008
23. D. R. Jones, G. Boysen and G. P. Miller, Novel multi-mode ultra performance liquid chromatography–tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma, J. Chromatogr. B879 (2011) 1056–1062; https://doi.org/10.1016/j.jchromb.2011.03.022
24. M.-J. Kwon, H.-J. Kim, J.-W. Kim, K.-H. Lee, K.-H. Sohn, H.-J. Cho, Y.-K. On, J.-S. Kim and S.-Y. Lee, Determination of plasma warfarin concentrations in Korean patients and its potential for clinical application, Korean J. Lab. Med.29 (2009) 515–523; https://doi.org/10.3343/kjlm.2009.29.6.515
25. A. N. Shaik, R. Grater, M. Lulla, D. A. Williams, L. L. Gan, T. Bohnert and B. W. LeDuc, Comparison of enzyme kinetics of warfarin analyzed by LC–MS/MS QTrap and differential mobility spectrometry, J. Chromatogr. B1008 (2016) 164–173; https://doi.org/10.1016/j.jchromb.2015.11.036
26. Z.-Y. Zhang, B. M. King and Y. N. Wong, Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies, Anal. Biochem.298 (2001) 40–49; https://doi.org/10.1006/abio.2001.5383
27. Y. Wong and P. Davis, Analysis of warfarin and its metabolites by reversed-phase ion-pair liquid chromatography with fluorescence detection, J. Chromatogr. A469 (1989) 281–291; https://doi.org/10.1016/S0021-9673(01)96463-5
28. S. H. Lee, L. Field, W. N. Howald and W. F. Trager, High-performance liquid chromatography separation and fluorescence detection of warfarin and its metabolites by postcolumn acid/base manipulation, Anal. Chem.53 (1981) 467–471; https://doi.org/10.1021/ac00226a019
30. C. Guo, S. Xue, X. Zheng, Y. Lu, D. Zhao, X. Chen and N. Li, The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats, Xenobiotica48 (2018) 400–406; https://doi.org/10.1080/00498254.2017.1306760